N39.4
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All patients who underwent surgical treatment of stress incontinence using a DynaMesh®-PRM/ -PRM visible mesh implant at the Vivantes Klinikum am Urban between July 2017 and October 2020 are included.
Exclusion criteria
Exclusion criteria: Since this is an observational study within the framework of usual treatment practice, there are no study-related exclusion criteria.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This observational study primarily serves to assess the performance of the product DynaMesh-PRM (visible) Recurrent incontinence and reoperation if recurrence to assess product performance | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary endpoints serve to assess the safety of the product DynaMesh-PRM (visible). Peri- and postoperative complications and follow-up data to assess safety | — |
Countries
Germany
Contacts
Klinik für Urologie, Vivantes Klinikum Am Urban